Preleukemia in children.
Preleukemia in children.
复制标题
儿童白血病前期。
DOI:
10.1016/s0022-3476(81)80761-5
复制
发表时间:
1981
期刊:
影响因子:
--
通讯作者:
Lange,B
中科院分区:
文献类型:
--
作者:
Blank,J;Lange,B
Six children who developed acute myelomonocytic leukemia presented with a preleukemic syndrome. The incidence of preleukemic presentation of AMML was 17% of children with acute nonlymphocytic leukemia, or 2.9% of all children with acute leukemia at this institution, incidences similar to those in adults. During the preleukemic phase, which lasted from three to 35 months, all children had anemia, all had infectious complications, and three of six had hemorrhagic tendencies. Three received steroids before the diagnosis of AMML, and all had some objective response. Two patients died before receiving therapy for AMML. Four children who received AMML therapy with combinations including cystosine arabinoside and an anthracycline achieved complete remission. Ultimately, all patients died. Clues to diagnosis of preleukemia include unexplained cytopenias, either absolute or functional, peripheral blasts, progressive megaloblastosis with an elevated B12value, dyserythropoiesis, abnormalities of nuclear segmentation, nonrandom chromosomal alterations, and reduced marrow colony to cluster ratio in vitro. Until there is a highly effective therapy for ANLL, precisely when to treat the child with preleukemia remains uncertain. However, treatment should be started before infectious complications or hemorrhagic tendencies become life-threatening.
登录
查看更多内容
影响因子:
6.2
作者:
M. Pierce;W. Borges;R. Heyn;J. Wolff;E. Gilbert
通讯作者:
E. Gilbert
影响因子:
8
作者:
Eledath U. Krishnan;K. Wegner;S. K. Garg
通讯作者:
S. K. Garg
影响因子:
158.5
作者:
D. Golde;M. Cline
通讯作者:
M. Cline
DOI:
10.1056/nejm198008283030901
发表时间:
1980
期刊:
The New England journal of medicine
影响因子:
--
作者:
H. Weinstein;R. Mayer;D. Rosenthal;B. Camitta;F. Coral;D. Nathan;E. Frei
通讯作者:
E. Frei
影响因子:
6.2
作者:
J. W. Linman;G. Bagby
通讯作者:
G. Bagby